Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism

Molecular and Cellular Biology

Volumn 29, Issue 13, 2009, Pages 3487-3499

  Ohashi, Koji ^a   Ouchi, Noriyuki ^a   Sato, Kaori ^a   Higuchi, Akiko ^a   Ishikawa, Tomo O ^b   Herschman, Harvey R ^b   Kihara, Shinji ^c   Walsh, Kenneth ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOPOIETIN RECEPTOR; CALRETICULIN; CRE RECOMBINASE; CYCLOOXYGENASE 2; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; GENE OVEREXPRESSION; HEART PROTECTION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIMB ISCHEMIA; MOUSE; MUSCLE ISCHEMIA; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVASCULARIZATION; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPONECTIN; ANIMALS; ANTIGENS, CD; CALRETICULIN; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; HEAT-SHOCK PROTEINS; HINDLIMB; HUMANS; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; MUS;

EID: 67650032832     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00126-09     Document Type: Article

References (62)

1. Abaci, A., A. Oguzhan, S. Kahraman, N. K. Eryol, S. Unal, H. Arinc, and A. Ergin. 1999. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99:2239-2242.
2. Ackah, E., J. Yu, S. Zoellner, Y. Iwakiri, C. Skurk, R. Shibata, N. Ouchi, R. M. Easton, G. Galasso, M. J. Birnbaum, K. Walsh, and W. C. Sessa. 2005. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Investig. 115:2119-2127.
3. Alva, J. A., A. C. Zovein, A. Monvoisin, T. Murphy, A. Salazar, N. L. Harvey, P. Carmeliet, and M. L. Iruela-Arispe. 2006. VE-Cadherin-Cre- recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235:759-767.
4. Arras, M., W. D. Ito, D. Scholz, B. Winkler, J. Schaper, and W. Schaper. 1998. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Investig. 101:40-50.
5. Basu, S., R. J. Binder, T. Ramalingam, and P. K. Srivastava. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-313.
6. Bayat, H., S. Xu, D. Pimentel, R. A. Cohen, and B. Jiang. 2008. Activation of thromboxane receptor upregulates interleukin (IL)-1beta-induced VCAM-1 expression through JNK signaling. Arterioscler. Thromb. Vasc. Biol. 28:127-134.
7. Cannon, C. P., S. P. Curtis, G. A. FitzGerald, H. Krum, A. Kaur, J. A. Bolognese, A. S. Reicin, C. Bombardier, M. E. Weinblatt, D. van der Heijde, E. Erdmann, and L. Laine. 2006. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 368:1771-1781.
8. Chen, H., M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon. 2003. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278:45021-45026.
9. Cheng, Y., S. C. Austin, B. Rocca, B. H. Koller, T. M. Coffman, T. Grosser, J. A. Lawson, and G. A. FitzGerald. 2002. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539-541.
10. Churchman, A., A. R. Baydoun, and R. Hoffman. 2007. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3- (methylsulfonyl) thiophene (DuP-697). Eur. J. Pharmacol. 573:176-183.
11. Dormond, O., A. Foletti, C. Paroz, and C. Ruegg. 2001. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat. Med. 7:1041-1047.
12. Francois, H., K. Athirakul, D. Howell, R. Dash, L. Mao, H. S. Kim, H. A. Rockman, G. A. Fitzgerald, B. H. Koller, and T. M. Coffman. 2005. Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metab. 2:201-207.
13. Gornik, H. L., and M. A. Creager. 2004. Arginine and endothelial and vascular health. J. Nutr. 134:2880S-2887S, 2895S.
14. Hara, A., K. Yuhki, T. Fujino, T. Yamada, K. Takayama, S. Kuriyama, O. Takahata, H. Karibe, Y. Okada, C. Y. Xiao, H. Ma, S. Narumiya, and F. Ushikubi. 2005. Augmented cardiac hypertrophy in response to pressure overload in mice lacking the prostaglandin I2 receptor. Circulation 112: 84-92.
15. Hu, P., B. Margolis, E. Y. Skolnik, R. Lammers, A. Ullrich, and J. Schlessinger. 1992. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell. Biol. 12:981-990.
16. Ikeda, Y., K. Ohashi, R. Shibata, D. R. Pimentel, S. Kihara, N. Ouchi, and K. Walsh. 2008. Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes. FEBS Lett. 582:1147-1150.
17. Ishikawa, T. O., and H. R. Herschman. 2006. Conditional knockout mouse for tissue-specific disruption of the cyclooxygenase-2 (Cox-2) gene. Genesis 44:143-149.
18. Kato, H., H. Kashiwagi, M. Shiraga, S. Tadokoro, T. Kamae, H. Ujiie, S. Honda, S. Miyata, Y. Ijiri, J. Yamamoto, N. Maeda, T. Funahashi, Y. Kurata, I. Shimomura, Y. Tomiyama, and Y. Kanakura. 2006. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler. Thromb. Vasc. Biol. 26:224-230.
19. Kawano, T., T. Saito, T. Yasu, T. Nakamura, K. Namai, H. Tamemoto, M. Kawakami, M. Saito, and S. E. Ishikawa. 2005. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Metabolism 54:653-656.
20. Kisanuki, Y. Y., R. E. Hammer, J. Miyazaki, S. C. Williams, J. A. Richardson, and M. Yanagisawa. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230:230-242.
21. Kobayashi, H., N. Ouchi, S. Kihara, K. Walsh, M. Kumada, Y. Abe, T. Funahashi, and Y. Matsuzawa. 2004. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94:e27-e31.
22. 2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J. Clin. Investig. 114:784-794.
23. Kubota, N., Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, W. Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki, and T. Noda. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277:25863- 25866.
24. Kumada, M., S. Kihara, S. Sumitsuji, T. Kawamoto, S. Matsumoto, N. Ouchi, Y. Arita, Y. Okamoto, I. Shimomura, H. Hiraoka, T. Nakamura, T. Funahashi, and Y. Matsuzawa. 2003. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol. 23: 85-89.
25. Ledoux, S., D. B. Campos, F. L. Lopes, M. Dobias-Goff, M. F. Palin, and B. D. Murphy. 2006. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 147:5178-5186.
26. Lindemann, S., C. Gierer, and H. Darius. 2003. Prostacyclin inhibits adhesion of polymorphonuclear leukocytes to human vascular endothelial cells due to adhesion molecule independent regulatory mechanisms. Basic Res. Cardiol. 98:8-15.
27. Massaro, M., A. Habib, L. Lubrano, S. Del Turco, G. Lazzerini, T. Bourcier, B. B. Weksler, and R. De Caterina. 2006. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc. Natl. Acad. Sci. USA 103:15184-15189.
28. McAdam, B. F., F. Catella-Lawson, I. A. Mardini, S. Kapoor, J. A. Lawson, and G. A. FitzGerald. 1999. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. USA 96:272-277.
29. Mukherjee, D., S. E. Nissen, and E. J. Topol. 2001. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286:954-959.
30. Munoz, C., D. Pascual-Salcedo, M. C. Castellanos, A. Alfranca, J. Aragones, A. Vara, J. M. Redondo, and M. O. de Landazuri. 1996. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood 88:3482-3490.
31. Nagata, D., M. Mogi, and K. Walsh. 2003. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J. Biol. Chem. 278:31000-31006.
32. Noon, J. P., B. R. Walker, D. J. Webb, A. C. Shore, D. W. Holton, H. V. Edwards, and G. C. Watt. 1997. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J. Clin. Investig. 99:1873-1879.
33. Ohashi, K., S. Kihara, N. Ouchi, M. Kumada, K. Fujita, A. Hiuge, T. Hibuse, M. Ryo, H. Nishizawa, N. Maeda, K. Maeda, R. Shibata, K. Walsh, T. Funahashi, and I. Shimomura. 2006. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47:1108-1116.
34. Okamoto, Y., E. J. Folco, M. Minami, A. K. Wara, M. W. Feinberg, G. K. Sukhova, R. A. Colvin, S. Kihara, T. Funahashi, A. D. Luster, and P. Libby. 2008. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ. Res. 102:218-225.
35. Okamoto, Y., S. Kihara, N. Ouchi, M. Nishida, Y. Arita, M. Kumada, K. Ohashi, N. Sakai, I. Shimomura, H. Kobayashi, N. Terasaka, T. Inaba, T. Funahashi, and Y. Matsuzawa. 2002. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770.
36. Orr, A. W., M. A. Pallero, W. C. Xiong, and J. E. Murphy-Ullrich. 2004. Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly. J. Biol. Chem. 279:48983-48992.
37. Ouchi, N., S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, S. Yamashita, T. Funahashi, and Y. Matsuzawa. 1999. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476.
38. Ouchi, N., S. Kihara, T. Funahashi, Y. Matsuzawa, and K. Walsh. 2003. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 14:561-566.
39. Ouchi, N., H. Kobayashi, S. Kihara, M. Kumada, K. Sato, T. Inoue, T. Funahashi, and K. Walsh. 2004. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279:1304-1309.
40. Ouchi, N., R. Shibata, and K. Walsh. 2005. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ. Res. 96:838-846.
41. Ouedraogo, R., Y. Gong, B. Berzins, X. Wu, K. Mahadev, K. Hough, L. Chan, B. J. Goldstein, and R. Scalia. 2007. Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J. Clin. Investig. 117:1718-1726.
42. Rudic, R. D., D. Brinster, Y. Cheng, S. Fries, W. L. Song, S. Austin, T. M. Coffman, and G. A. FitzGerald. 2005. COX-2-derived prostacyclin modulates vascular remodeling. Circ. Res. 96:1240-1247.
43. Scherer, P. E., S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270:26746-26749.
44. Sheu, M. L., F. M. Ho, R. S. Yang, K. F. Chao, W. W. Lin, S. Y. Lin-Shiau, and S. H. Liu. 2005. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler. Thromb. Vasc. Biol. 25:539-545.
45. Shibata, R., N. Ouchi, M. Ito, S. Kihara, I. Shiojima, D. R. Pimentel, M. Kumada, K. Sato, S. Schiekofer, K. Ohashi, T. Funahashi, W. S. Colucci, and K. Walsh. 2004. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10:1384-1389.
46. Shibata, R., N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh. 2004. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J. Biol. Chem. 279: 28670-28674.
47. Shibata, R., K. Sato, D. R. Pimentel, Y. Takemura, S. Kihara, K. Ohashi, T. Funahashi, N. Ouchi, and K. Walsh. 2005. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11:1096-1103.
48. Shiojima, I., and K. Walsh. 2002. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90:1243-1250.
49. + mononuclear cells through the expression of interleukin-16. Circulation 113:118-124.
50. Steinbach, G., P. M. Lynch, R. K. Phillips, M. H. Wallace, E. Hawk, G. B. Gordon, N. Wakabayashi, B. Saunders, Y. Shen, T. Fujimura, L. K. Su, and B. Levin. 2000. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342:1946-1952.
51. Takemura, Y., N. Ouchi, R. Shibata, T. Aprahamian, M. T. Kirber, R. S. Summer, S. Kihara, and K. Walsh. 2007. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J. Clin. Investig. 117:375-386.
52. Tang, C. H., R. S. Yang, T. H. Huang, D. Y. Lu, W. J. Chuang, T. F. Huang, and W. M. Fu. 2006. Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol. Pharmacol. 69: 2047-2057.
53. Tao, L., E. Gao, X. Jiao, Y. Yuan, S. Li, T. A. Christopher, B. L. Lopez, W. Koch, L. Chan, B. J. Goldstein, and X. L. Ma. 2007. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115:1408-1416.
54. Tsuchihashi, H., H. Yamamoto, K. Maeda, S. Ugi, T. Mori, T. Shimizu, Y. Endo, K. Hanasawa, and T. Tani. 2006. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J. Surg. Res. 134:348-353.
55. Vandivier, R. W., C. A. Ogden, V. A. Fadok, P. R. Hoffmann, K. K. Brown, M. Botto, M. J. Walport, J. H. Fisher, P. M. Henson, and K. E. Greene. 2002. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169:3978-3986.
56. Williams, C. S., M. Tsujii, J. Reese, S. K. Dey, and R. N. DuBois. 2000. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Investig. 105:1589-1594.
57. 2 in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation 104:2210-2215.
58. Yamauchi, T., J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N. H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769.
59. Yamauchi, T., Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki, and T. Kadowaki. 2007. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13:332-339.
60. Yang, T., Y. G. Huang, W. Ye, P. Hansen, J. B. Schnermann, and J. P. Briggs. 2005. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am. J. Physiol. Renal Physiol. 288:F1125-F1132.
61. Yokota, T., C. S. Meka, K. L. Medina, H. Igarashi, P. C. Comp, M. Takahashi, M. Nishida, K. Oritani, J. Miyagawa, T. Funahashi, Y. Tomiyama, Y. Matsuzawa, and P. W. Kincade. 2002. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J. Clin. Investig. 109:1303-1310.
62. Zucker, T. P., D. Bonisch, A. Hasse, T. Grosser, A. A. Weber, and K. Schror. 1998. Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells. Eur. J. Pharmacol. 345:213-220.